The sales are small in both absolute and relative terms and do not signal material concern. Traders should monitor for larger or more concentrated selling patterns before inferring negative sentiment.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 1 $203.21entry
- T+1 · 8mo ago +2.35%α +2.27% · $207.98
- T+5 · 7mo ago −0.10%α −3.87% · $203.00
- T+20 · 7mo ago −4.16%α −13.89% · $194.75
- T+60 · 5mo ago +34.00%α +20.62% · $272.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Natera executives sold $271K in shares over a 7-day window, including a $211K sale by President Solomon Moshkevich and a $60K sale by Chief Legal Officer Daniel Rabinowitz. These open-market sales are routine in size and not material relative to the company's $29.7B market cap.
Key Financial Metrics
Key Facts
- Two insiders conducted open-market sales totaling $271K within a 7-day period.
- Solomon Moshkevich (President, ClinicalDiagnostics) sold 1,000 shares for $211K.
- Daniel Rabinowitz (Chief Legal Officer) sold 300 shares for $60K.
- No open-market purchases were reported in this cluster.
- All transactions were standard S (sale) codes; no grants, awards, or derivative exercises included in this cluster.
Financial Impact
Total value of $271K represents less than 0.001% of Natera's $29.7B market cap, immaterial.
Risk Factors
- Concentrated insider selling could emerge if additional executives participate in future transactions.
- Perception risk if media or retail investors misinterpret routine transactions as bearish.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NTRA-1775696734621 |
Track record
63 reports on NTRA
6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $288.48 −3.98% settles Nov 17
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
- Nov 10, 20266d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $288.48 −26.23% ▼ −6.97% −2.56% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers